NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
69,147,487
Share change
-1,211,080
Total reported value
$4,099,622,932
Put/Call ratio
172%
Price per share
$59.30
Number of holders
257
Value change
-$81,841,604
Number of buys
139
Number of sells
127

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q2 2020

As of 30 Jun 2020, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 257 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,147,487 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Capital World Investors, BlackRock Inc., Capital International Investors, CREDIT SUISSE AG/, RENAISSANCE TECHNOLOGIES LLC, WELLINGTON MANAGEMENT GROUP LLP, and Darsana Capital Partners LP. This page lists 257 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.